CONCURRENT IMMUNE CHECKPOINT INHIBITION AND SELECTIVE IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH IMMUNE-RELATED ENTEROCOLITIS

被引：0
|
作者：
Badran, Yousef R.
Zou, Fangwen
Durbin, Sienna
Dutra, Barbara E.
Leet, Donna
Abu-Sbeih, Hamzah
Thomas, Anusha Shirwaikar
Postow, Michael
Horick, Nora
Lai, Po-Ying
Faleck, David M.
Wang, Yinghong
Dougan, Michael
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
375
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [1] Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
    Badran, Yousef R.
    Zou, Fangwen
    Durbin, Sienna M.
    Dutra, Barbara E.
    Abu-Sbeih, Hamzah
    Thomas, Anusha S.
    Altan, Mehmet
    Thompson, John A.
    Qiao, Wei
    Leet, Donna E.
    Lai, Po-Ying
    Horick, Nora K.
    Postow, Michael A.
    Faleck, David M.
    Wang, Yinghong
    Dougan, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (06)
  • [2] Cardiac Immune-Related Adverse Events in Immune Checkpoint Inhibition Therapy
    Brumbaugh, Aaron D.
    Narurkar, Roshni
    Parikh, Kaushal
    Fanucchi, Michael
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2019, 27 (02) : 97 - 107
  • [3] Immune-related endocrine disorders in novel immune checkpoint inhibition therapy
    Min, Le
    GENES & DISEASES, 2016, 3 (04) : 252 - 256
  • [4] Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
    Badran, Yousef R.
    Cohen, Justine, V
    Brastianos, Priscilla K.
    Parikh, Aparna R.
    Hong, Theodore S.
    Dougan, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [5] CONCURRENT THERAPY WITH IMMUNE CHECKPOINT INHIBITORS AND TNF BLOCKADE IN PATIENTS WITH GASTROINTESTINAL IMMUNE-RELATED ADVERSE EVENTS
    Badran, Yousef R.
    Leet, Donna
    Cohen, Justine V.
    Brastianos, Priscilla K.
    Parikh, Aparna
    Hong, Theodore S.
    Dougan, Michael
    GASTROENTEROLOGY, 2020, 158 (06) : S538 - S538
  • [6] Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment
    Machado, Antonio Pizuorno
    Shatila, Malek
    Oliva, Isabella C. Glitza C.
    Altan, Mehmet
    Siddiqui, Bilal
    Zhou, Yan
    Varatharajalu, Krishnavathana
    Zhang, Hao Chi
    Thomas, Anusha
    Wang, Yinghong
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (08): : 360 - 365
  • [7] Immune-related encephalitis after immune checkpoint inhibitor therapy
    Buckley, Monica W.
    Balaji Warner, Aanika
    Brahmer, Julie
    Cappelli, Laura C.
    Sharfman, William H.
    Fuchs, Ephraim
    Kang, Hyunseok
    Forde, Patrick M.
    Gladstone, Douglas E.
    Ambinder, Richard
    Kelly, Ronan J.
    Lipson, Evan J.
    Gojo, Ivana
    Lee, Edward J.
    Johnson, Tory P.
    Saidha, Shiv
    Llinas, Rafael
    Ostrow, Lyle W.
    Naidoo, Jarushka
    Probasco, John C.
    ONCOLOGIST, 2024, 30 (01):
  • [8] Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition
    Peter Chei-way Pan
    Aya Haggiagi
    Current Oncology Reports, 2019, 21
  • [9] Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition
    Pan, Peter Chei-way
    Haggiagi, Aya
    CURRENT ONCOLOGY REPORTS, 2019, 21 (12)
  • [10] Impact of immunosuppressive agents on the management of immune-related adverse events of immune checkpoint blockers
    Cariou, Pierre-Louis
    Pobel, Cedric
    Michot, Jean-Marie
    Danlos, Francois-Xavier
    Besse, Benjamin
    Carbonnel, Franck
    Mariette, Xavier
    Marabelle, Aurelien
    Messayke, Sabine
    Robert, Caroline
    Routier, Emilie
    Noel, Nicolas
    Lambotte, Olivier
    EUROPEAN JOURNAL OF CANCER, 2024, 204
12345